real world evidence rwe real world data rwd webinar programmers drug development Wisdom from the Front Lines of Successful NDA Submission Statistical Clinical Programming biostatistics cro mms holdings vendor services pharmaceutical industry biotech

MMS is proud to present our latest webinar – Wisdom from the Front Lines of Successful NDA Submission Programming: Utilizing the Biometrics Operational Data Model.

In this free, on-demand webinar you will discover:

  • The Biometrics Operational Data Model and explain how submission work can be streamlined across programmers and statisticians
  • Validation needs within a submission
  • The importance of reviewer’s guides and when they should be built
  • Why the NDA submission should be considered during early phases
  • Trial domains and how they relate to SDTM, ADaM, and TLFs
  • Items that are easy to overlooked during submission planning

Panelists include:

  • Jim Bademian, Global Head of Statistical Programming, MMS, North Carolina
  • Susheel Arkala, Principal Clinical Programmer and Associate Manager of Programming, MMS, Oregon
  • Chris Hurley, Senior Manager of Global Data Operations, Standards and Systems, MMS, Michigan

View the webinar here

Wisdom from the Front Lines of Successful NDA Submission Programming mms holdings webinar pharma cro biostatistics clinical statistical

Run time: 40:47

Suggested For You

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

perspectives

August 20th, 2024

Clinical Study Protocols: A Comprehensive Guide to Best Practices From A Senior Medical Writer

perspectives

August 13th, 2024

How To Navigate The Nonclinical Evaluation Landscape Of Biopharmaceuticals

perspectives

August 5th, 2024

Ensuring Robust Data Privacy and Protection: An Overview of the MMS Framework

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma